Skip to content

Study of the effect of black garlic on immunity and coagulation in healthy volunteers

Study of the effect of black garlic on immunity and coagulation in healthy volunteers

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210610001
Enrollment
15
Registered
2021-06-10
Start date
2021-08-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunity Immunity

Interventions

Black garlic 5 mg two times a day before breakfast and dinner for 56 days ,Black garlic 10 mg two times a day before breakfast and dinner for 56 days ,Placebo 5 or 10 g two times a day before breakfas
Black garlic 10 g,Black garlic 20 g,Placebo

Sponsors

Department of Pharmacology, Faculty of Medicine, Chiang Mai University
Lead Sponsor
Department of Pharmacology, Faculty of Medicine, Chiang Mai University
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Male and female Healthy volunteer aged 20-45 years; No significant underlying disease; All patients will be informed both verbally and in writing of the possible risks and adverse events which may occur during the study and must sign the written consent forms to participate in the study.

Exclusion criteria

Exclusion criteria: Abnormal finding after physical examination BMI more than or equal to 25 kg/m2 Clinically significant abnormalities in blood chemistry and hematology: o Hemoglobin < 10 g/dL o White blood cells < 4,000 per cu. mm. o Platelets < 100,000 per cu. mm. o Alanine aminotransferase (ALT), aspartate aminotransferase (AST), or alkaline phosphatase more than 2 times the upper limit of normal o Blood urea nitrogen (BUN) more than 20 mg/dL, creatinine more than 1.5 times the upper limit of normal o Abnormal urine examination o Prothrombin time (PT) more than 13.0 sec, international normalized ratio (INR) more than 5, or partial thromboplastin time (PTT) more than 38.9 sec Unable to participate throughout the study period Have a history of hypersensitivity to garlic or black garlic Smoking Pregnant or lactating;

Design outcomes

Primary

MeasureTime frame
Cytokines Day 0, 1, 28, 56 ELISA,White blood cells Day 0, 1, 28, 56 Flow cytometry

Secondary

MeasureTime frame
Platelet aggregation Day 0, 28, 56 Platelet aggregometry,Coagulation Day 0, 28, 56 PT, PTT, INR,Safety Day 0, 14, 28, 56 CBC, BUN, Cr, LFT, U/A,VASP Day 0, 28, 56 VASP phosphorylation assay

Countries

Thailand

Contacts

Public ContactNutthiya Hanprasertpong

Department of Pharmacology, Faculty of Medicine, Chiang Mai University

nutthiya.h@cmu.ac.th053935353

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026